A Double-Edged Function of DDX3, as an Oncogene or Tumor Suppressor, in Cancer Progression (Review)

Oncology Reports - Greece
doi 10.3892/or.2018.6203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor

Genes
Genetics
2018English

DYRK1A in Down Syndrome: An Oncogene or Tumor Suppressor?

Journal of Clinical Investigation
Medicine
2012English

AMPK: A Contextual Oncogene or Tumor Suppressor?

Cancer Research
Cancer ResearchOncology
2013English

SIRT3: Oncogene and Tumor Suppressor in Cancer

Cancers
Cancer ResearchOncology
2017English

DNA Repair in Cancer Initiation, Progression, and Therapy—a Double-Edged Sword

Journal of Applied Genetics
MedicineGenetics
2019English

PAX3: A Molecule With Oncogenic or Tumor Suppressor Function Is Involved in Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

GPRC5A: A Potential Tumor Suppressor and Oncogene

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2019English

The False Paradigm of RUNX3 Function as Tumor Suppressor in Gastric Cancer

Journal of Cancer Therapy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy